Skip to main content
Main navigation
Home
About pCPA
Who We Are
Governance
FAQs
Negotiations
Recent Updates
Forms and Publications
Brand Name Drugs
Negotiations Status
Negotiation Process
Generic Drugs
Biologics/Biosimilars
Contact Us
EN
FR
Taltz (ixekizumab)
pCPA File Number:
21192
Negotiation Status:
Concluded without agreement
Indication(s):
Ankylosing spondylitis
Sponsor/Manufacturer:
Eli Lilly Canada Inc.
CADTH Project Number:
SR0630-000
pCPA Engagement Letter Issued:
2021-01-13
Negotiation Process Concluded:
2021-03-19